Wallace Kristin, Nahhas Georges J, Bookhout Christine, Lewin David N, Paulos Chrystal M, Nikolaishvili-Feinberg Nana, Cohen Stephanie M, Guglietta Silvia, Bakhtiari Ali, Camp E Ramsay, Hill Elizabeth G, Baron John A, Wu Jennifer D, Alekseyenko Alexander V
Hollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, SC, United States.
Department of Public Health Sciences, MUSC, Charleston, SC, United States.
Front Oncol. 2021 Apr 27;11:659036. doi: 10.3389/fonc.2021.659036. eCollection 2021.
African Americans (AAs) have higher colorectal cancer (CRC) incidence and mortality rate than Caucasian Americans (CAs). Recent studies suggest that immune responses within CRCs contribute to the disparities. If racially distinct immune signatures are present in the early phases of carcinogenesis, they could be used to develop interventions to prevent or slow disease.
We selected a convenience sample of 95 patients (48 CAs, 47 AAs) with preinvasive colorectal adenomas from the surgical pathology laboratory at the Medical University of South Carolina. Using immunofluorescent-conjugated antibodies on tissue slides from the lesions, we quantified specific immune cell populations: mast cells (CD117), Th17 cells (CD4RORC), and NK cell ligand (MICA/B) and inflammatory cytokines, including , and . We compared the mean density counts (MDCs) and density rate ratios (RR) and 95% CI of immune markers between AAs to CAs using negative binomial regression analysis. We adjusted our models for age, sex, clinicopathologic characteristics (histology, location, dysplasia), and batch.
We observed no racial differences in age or sex at the baseline endoscopic exam. AAs compared to CAs had a higher prevalence of proximal adenomas (66% 40%) and a lower prevalence of rectal adenomas (11% 23%) (p =0.04) but no other differences in pathologic characteristics. In age, sex, and batch adjusted models, AAs CAs had lower RRs for cells labeled with IFNγ (RR 0.50 (95% CI 0.32-0.81); p=0.004) and NK cell ligand (RR 0.67 (0.43-1.04); p=0.07). In models adjusted for age, sex, and clinicopathologic variables, AAs had reduced RRs relative to CAs for CD4 (p=0.02), NK cell ligands (p=0.01), Th17 (p=0.005), mast cells (p=0.04) and IFN-γ (p< 0.0001).
Overall, the lower RRs in AAs CAs suggests reduced effector response capacity and an immunosuppressive ('cold') tumor environment. Our results also highlight the importance of colonic location of adenoma in influencing these differences; the reduced immune responses in AAs relative to CAs may indicate impaired immune surveillance in early carcinogenesis. Future studies are needed to understand the role of risk factors (such as obesity) in influencing differences in immune responses by race.
非裔美国人(AAs)的结直肠癌(CRC)发病率和死亡率高于白种美国人(CAs)。最近的研究表明,结直肠癌中的免疫反应导致了这种差异。如果在致癌作用的早期阶段存在种族特异性的免疫特征,那么它们可用于开发预防或减缓疾病的干预措施。
我们从南卡罗来纳医科大学外科病理实验室选取了95例患有浸润前结直肠腺瘤的患者作为便利样本(48例CAs,47例AAs)。使用针对病变组织切片的免疫荧光偶联抗体,我们对特定免疫细胞群体进行了定量:肥大细胞(CD117)、Th17细胞(CD4RORC)、NK细胞配体(MICA/B)以及炎症细胞因子,包括 ,和 。我们使用负二项回归分析比较了AAs与CAs之间免疫标志物的平均密度计数(MDCs)、密度率比(RR)和95%置信区间。我们对模型进行了年龄、性别、临床病理特征(组织学、位置、发育异常)和批次的调整。
在基线内镜检查时,我们未观察到年龄或性别方面的种族差异。与CAs相比,AAs近端腺瘤的患病率更高(66% 对40%),直肠腺瘤的患病率更低(11% 对23%)(p = 0.04),但在病理特征方面没有其他差异。在年龄、性别和批次调整的模型中,AAs与CAs相比,IFNγ标记细胞的RR较低(RR 0.50(95% CI 0.32 - 0.81);p = 0.004),NK细胞配体的RR较低(RR 0.67(0.43 - 1.04);p = 0.07)。在针对年龄、性别和临床病理变量调整的模型中,AAs相对于CAs,CD4(p = 0.02)、NK细胞配体(p = 0.01)、Th17(p = 0.005)、肥大细胞(p = 0.04)和IFN - γ(p < 0.0001)的RR降低。
总体而言,AAs与CAs相比RR较低表明效应器反应能力降低以及肿瘤环境具有免疫抑制性(“冷”)。我们的结果还突出了腺瘤的结肠位置在影响这些差异方面的重要性;AAs相对于CAs免疫反应降低可能表明早期致癌过程中免疫监视受损。未来需要开展研究以了解风险因素(如肥胖)在影响种族间免疫反应差异方面的作用。